Literature DB >> 29082441

Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice.

Anne D Thuesen1, Kenneth Andersen1, Kristina S Lyngsø1, Mark Burton2, Charlotte Brasch-Andersen2, Paul M Vanhoutte3, Pernille B L Hansen4,5.   

Abstract

Impairment of endothelial function with aging is accompanied by reduced nitric oxide (NO) production. T-type Cav3.1 channels augment nitric oxide and co-localize with eNOS. Therefore, the hypothesis was that T-type channels contribute to the endothelial dysfunction of aging. Endothelial function was determined in mesenteric arteries (perfusion) and aortae (isometric contraction) of young and old wild-type (WT), Cav3.1, and Cav3.2 knockout mice. NO production was measured by fluorescence imaging in mesenteric arteries. With age, endothelium-dependent subsequent dilatation (following depolarization with KCl) of mesenteric arteries was diminished in the arteries of WT mice, unchanged in Cav3.2-/- preparations but increased in those of Cav3.1-/- mice. NO synthase inhibition abolished the subsequent dilatation in mesenteric arteries and acetylcholine-induced relaxations in aortae. NO levels were significantly reduced in mesenteric arteries of old compared to young WT mice. In Cav3.1-/- and Cav3.2-/- preparations, NO levels increased significantly with age. Relaxations to acetylcholine were significantly smaller in the aortae of old compared to young WT mice, while such responses were comparable in preparations of young and old Cav3.1-/- and Cav3.2-/- mice. The expression of Cav3.1 was significantly reduced in aortae from aged compared to young WT mice. The level of phosphorylated eNOS was significantly increased in aortae from aged Cav3.1-/- mice. In conclusion, T-type calcium channel-deficient mice develop less age-dependent endothelial dysfunction. Changes in NO levels are involved in this phenomenon in WT and Cav3.1-/- mice. These findings suggest that T-type channels play an important role in age-induced endothelial dysfunction.

Entities:  

Keywords:  Endothelial dysfunction; NO; T-type calcium channels; Vasodilatation

Mesh:

Substances:

Year:  2017        PMID: 29082441     DOI: 10.1007/s00424-017-2068-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  56 in total

1.  Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.

Authors:  Lauren Howitt; Ivana Y Kuo; Anthie Ellis; Daniel J Chaston; Hee-Sup Shin; Pernille B Hansen; Caryl E Hill
Journal:  Cardiovasc Res       Date:  2013-02-22       Impact factor: 10.787

Review 2.  Mitochondria and endothelial function.

Authors:  Matthew A Kluge; Jessica L Fetterman; Joseph A Vita
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

Review 3.  Nitric oxide: orchestrator of endothelium-dependent responses.

Authors:  Michel Félétou; Ralf Köhler; Paul M Vanhoutte
Journal:  Ann Med       Date:  2011-09-07       Impact factor: 4.709

4.  Oxygen-derived free radicals mediate endothelium-dependent contractions in femoral arteries of rats with streptozotocin-induced diabetes.

Authors:  Y Shi; K-F So; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

5.  Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction.

Authors:  Liming Wang; Jun Yin; Hannah T Nickles; Hannes Ranke; Arata Tabuchi; Julia Hoffmann; Christoph Tabeling; Eduardo Barbosa-Sicard; Marc Chanson; Brenda R Kwak; Hee-Sup Shin; Songwei Wu; Brant E Isakson; Martin Witzenrath; Cor de Wit; Ingrid Fleming; Hermann Kuppe; Wolfgang M Kuebler
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

6.  Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt.

Authors:  Brynhildur Thors; Haraldur Halldórsson; Gudmundur Thorgeirsson
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

Review 7.  Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.

Authors:  Nicholas J Alp; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-04       Impact factor: 8.311

8.  Ageing suppresses endothelium-dependent relaxation and generates contraction mediated by the muscarinic receptors in vascular smooth muscle of normotensive Wistar-Kyoto and spontaneously hypertensive rats.

Authors:  T Koga; Y Takata; K Kobayashi; S Takishita; Y Yamashita; M Fujishima
Journal:  J Hypertens Suppl       Date:  1988-12

9.  Chronic treatment with the CA2+ channel inhibitor RO 40-5967 potentiates endothelium-dependent relaxations in the aorta of the hypertensive salt sensitive Dahl rat.

Authors:  C M Boulanger; B Desta; J P Clozel; P M Vanhoutte
Journal:  Blood Press       Date:  1994-05       Impact factor: 2.835

10.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  T F Lüscher; P M Vanhoutte
Journal:  Hypertension       Date:  1986-04       Impact factor: 10.190

View more
  4 in total

1.  Stimulated phosphorylation of ERK in mouse kidney mesangial cells is dependent upon expression of Cav3.1.

Authors:  Sudha Priya Soundara Pandi; Michael J Shattock; Bruce M Hendry; Claire C Sharpe
Journal:  BMC Nephrol       Date:  2022-06-16       Impact factor: 2.585

Review 2.  Vascular calcium signalling and ageing.

Authors:  Osama F Harraz; Lars Jørn Jensen
Journal:  J Physiol       Date:  2021-11-21       Impact factor: 6.228

Review 3.  Genetic T-type calcium channelopathies.

Authors:  Norbert Weiss; Gerald W Zamponi
Journal:  J Med Genet       Date:  2019-06-19       Impact factor: 6.318

4.  Breeding of Cav2.3 deficient mice reveals Mendelian inheritance in contrast to complex inheritance in Cav3.2 null mutant breeding.

Authors:  Anna Papazoglou; Christina Henseler; Karl Broich; Johanna Daubner; Marco Weiergräber
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.